Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Murphy

Showing results (31-40 of 176) with videos related to

Pageof 18
Sort By:
Antiviral Therapy|March 9, 2005
Challenges for the clinical development of new nucleoside reverse transcriptase inhibitors for HIV infectionMark A Wainberg, James P C Sawyer, Julio S G Montaner, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2016
Pharmacokinetics and tolerability of ABX464, a novel first-in-class compound to treat HIV infection, in healthy HIV-uninfected subjectsDidier Scherrer, Regine Rouzier, P Noel Barrett, et al.
AIDS (London, England)|June 4, 2019
Excess early mortality in HIV/hepatitis B virus co-infected patients initiating antiretroviral therapy in KenyaMurithi Mbae, Leah Owen, Kirwa Kiprono Elisha, et al.
Antiviral Therapy|April 14, 2010
Antiviral activity and tolerability of amdoxovir with zidovudine in a randomized double-blind placebo-controlled study in HIV-1-infected individualsRobert L Murphy, Nancy M Kivel, Carlos Zala, et al.
Ophthalmology|May 10, 2005
Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapyDouglas A Jabs, Janet T Holbrook, Mark L Van Natta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2013
Assessment of liver fibrosis by transient elastography in patients with HIV and hepatitis B virus coinfection in NigeriaClaudia Hawkins, Oche Agbaji, Placid Ugoagwu, et al.
JCO Global Oncology|June 18, 2025
Emerging Trends in Point-of-Care Technology Development for Oncology in Low- and Middle-Income CountriesWenting Gao, Jason C Manning, Kirtana Devaraj, et al.
AIDS Research and Therapy|October 15, 2017
Drug resistance patterns following pharmacy stock shortage in Nigerian Antiretroviral Treatment ProgramSeema T Meloni, Beth Chaplin, John Idoko, et al.
Archives of Gynecology and Obstetrics|May 24, 2013
High-risk human papillomavirus among HIV-infected women with normal cervical cytology: a pilot study in Jos, NigeriaJonah Musa, Babafemi Taiwo, Chad Achenbach, et al.
AIDS Research and Human Retroviruses|January 16, 2013
Tuberculosis after one year of combination antiretroviral therapy in Nigeria: a retrospective cohort studyMaxwell O Akanbi, Chad J Achenbach, Joe Feinglass, et al.
Pageof 18

Showing results (31-40 of 176) with videos related to

Sort By:
Pageof 18
Antiviral Therapy|March 9, 2005
Challenges for the clinical development of new nucleoside reverse transcriptase inhibitors for HIV infectionMark A Wainberg, James P C Sawyer, Julio S G Montaner, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2016
Pharmacokinetics and tolerability of ABX464, a novel first-in-class compound to treat HIV infection, in healthy HIV-uninfected subjectsDidier Scherrer, Regine Rouzier, P Noel Barrett, et al.
AIDS (London, England)|June 4, 2019
Excess early mortality in HIV/hepatitis B virus co-infected patients initiating antiretroviral therapy in KenyaMurithi Mbae, Leah Owen, Kirwa Kiprono Elisha, et al.
Antiviral Therapy|April 14, 2010
Antiviral activity and tolerability of amdoxovir with zidovudine in a randomized double-blind placebo-controlled study in HIV-1-infected individualsRobert L Murphy, Nancy M Kivel, Carlos Zala, et al.
Ophthalmology|May 10, 2005
Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapyDouglas A Jabs, Janet T Holbrook, Mark L Van Natta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2013
Assessment of liver fibrosis by transient elastography in patients with HIV and hepatitis B virus coinfection in NigeriaClaudia Hawkins, Oche Agbaji, Placid Ugoagwu, et al.
JCO Global Oncology|June 18, 2025
Emerging Trends in Point-of-Care Technology Development for Oncology in Low- and Middle-Income CountriesWenting Gao, Jason C Manning, Kirtana Devaraj, et al.
AIDS Research and Therapy|October 15, 2017
Drug resistance patterns following pharmacy stock shortage in Nigerian Antiretroviral Treatment ProgramSeema T Meloni, Beth Chaplin, John Idoko, et al.
Archives of Gynecology and Obstetrics|May 24, 2013
High-risk human papillomavirus among HIV-infected women with normal cervical cytology: a pilot study in Jos, NigeriaJonah Musa, Babafemi Taiwo, Chad Achenbach, et al.
AIDS Research and Human Retroviruses|January 16, 2013
Tuberculosis after one year of combination antiretroviral therapy in Nigeria: a retrospective cohort studyMaxwell O Akanbi, Chad J Achenbach, Joe Feinglass, et al.
Pageof 18